 |
|
 |
| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7138122 |
Therapeutic systems |
Nov. 21, 2006 |
| 7125873 |
Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
Oct. 24, 2006 |
| 7122536 |
(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
Oct. 17, 2006 |
| 7122535 |
Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
Oct. 17, 2006 |
| 7122534 |
Aryl fused azapolycyclic compounds |
Oct. 17, 2006 |
| 7115637 |
Inhibitors of p38 |
Oct. 3, 2006 |
| 7115577 |
Colorectal neoplasia prophylaxis |
Oct. 3, 2006 |
| 7112587 |
Methods and compositions of novel triazine compounds |
Sep. 26, 2006 |
| 7112581 |
Macrocyclic lactams |
Sep. 26, 2006 |
| 7109189 |
Mitochondrially targeted antioxidants |
Sep. 19, 2006 |
| 7101867 |
Benzofuran derivatives, their production and use |
Sep. 5, 2006 |
| 7101868 |
Substituted arylamine derivatives and methods of use |
Sep. 5, 2006 |
| 7098198 |
Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
Aug. 29, 2006 |
| 7098200 |
[[2-(Amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
Aug. 29, 2006 |
| 7098201 |
Heteroaromatic derivatives having an inhibitory activity against HIV integrase |
Aug. 29, 2006 |
| 7098202 |
Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
Aug. 29, 2006 |
| 7094378 |
Method and apparatus for inactivation of biological contaminants using photosensitizers |
Aug. 22, 2006 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 7091196 |
Bifunctional heterocyclic compounds and methods of making and using same |
Aug. 15, 2006 |
| 7087593 |
Benzimidazolidinone derivatives as muscarinic agents |
Aug. 8, 2006 |
| 7081452 |
Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
Jul. 25, 2006 |
| 7078054 |
Soft gelatin capsule manufacture |
Jul. 18, 2006 |
| 7078418 |
1-aziridino-1-hydroxyiminomethyl-derivates, method for the production thereof and medicaments containing said compounds |
Jul. 18, 2006 |
| 7074780 |
Substituted phenylcyclohexanecarboxamides and their use |
Jul. 11, 2006 |
| 7071158 |
Antioxidant enhancement of therapy for hyperproliferative conditions |
Jul. 4, 2006 |
| 7071180 |
Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
Jul. 4, 2006 |
| RE39148 |
Potentiation of the Microbicide 2-(Thiocyanomethylthio)benzothiazole using an n-alkyl heterocyclic compound |
Jun. 27, 2006 |
| 7067506 |
Compounds useful for inhibiting Chk1 |
Jun. 27, 2006 |
| 7067507 |
Macrocycles useful in the treatment of Alzheimer's disease |
Jun. 27, 2006 |
| 7067508 |
Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation |
Jun. 27, 2006 |
| 7064132 |
Composition and method for treatment of otitis external |
Jun. 20, 2006 |
| 7060711 |
Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT.sub.2B receptor antagonist |
Jun. 13, 2006 |
| 7053078 |
Serine protease inhibitors |
May. 30, 2006 |
| 7053120 |
Use of carboxy compounds such as 2(4-acetoxyphenyl)2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents |
May. 30, 2006 |
| 7049306 |
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
May. 23, 2006 |
| 7045495 |
Combination of bryostatin and paclitaxel for treating cancer |
May. 16, 2006 |
| 7045514 |
Therapeutic heterocyclic compounds |
May. 16, 2006 |
| 7045523 |
Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-p- yridyl)-2-pyrimidine-amine and telomerase inhibitor |
May. 16, 2006 |
| 7045547 |
Acyl-CoA dehydrogenase allenic inhibitors |
May. 16, 2006 |
| 7041659 |
Compounds for the treatment of metabolic disorders |
May. 9, 2006 |
| 7033999 |
Nitrosated and nitrosylated heme proteins |
Apr. 25, 2006 |
| 7030085 |
Thiopeptide compounds |
Apr. 18, 2006 |
| 7030110 |
Cyclic oxyguanidine pyrazinones as protease inhibitors |
Apr. 18, 2006 |
| 7030147 |
Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
Apr. 18, 2006 |
| 7026307 |
Method for producing 1,3-disubstituted 2-nitroguanidines |
Apr. 11, 2006 |
| 7022330 |
Parenteral formulation for epothilone analogs |
Apr. 4, 2006 |
| 7022689 |
5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
Apr. 4, 2006 |
| 7022690 |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
Apr. 4, 2006 |
| 7018996 |
Antibiotics AW998A, AW998B, AW998C and AW998D |
Mar. 28, 2006 |
| RE39033 |
Potentiation of the microbicide 2-(thiocyanomethylthio)benzothiazole using an N-alkyl heterocyclic compound |
Mar. 21, 2006 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
